• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CORCYM CANADA CORP. PERCEVAL PLUS SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CORCYM CANADA CORP. PERCEVAL PLUS SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVES Back to Search Results
Model Number PVF-XL
Device Problem Inadequacy of Device Shape and/or Size (1583)
Patient Problem Aortic Valve Insufficiency/ Regurgitation (4450)
Event Date 03/11/2022
Event Type  Injury  
Manufacturer Narrative
A complete manufacturing and material records review for the component has been performed.The results confirmed that the component satisfied all material, visual and performance standards required at the time of manufacture and release.Based on the information received, the cause of the reported event was attributed to the mis-sizing (reportedly, the valve was too small).No device malfunction or adverse event on the patient has been reported and patient had a good outcome.Furthermore, from the document review performed, no manufacturing deficiencies were identified.As such, no further investigation is warranted.Should further information be received in the future, the manufacturer will provide a follow up report.
 
Event Description
The manufacturer was informed of this event through patient tracking database.Based on the information on the patient's implant from, pvf-xl which was implanted on (b)(6) 2021 was explanted on (b)(6) 2022, and cna27 was implanted in the patient as a replacement.Based on the information received, the valve was explanted due to the perivalvular leak and it was determined to be too small.As reported, during the initial implant it was thought that xl could be used although it was on the upper end of the valve¿s acceptable range.The patient wasn¿t doing well upon follow up and a leak was found around the valve.Thus, the valve was explanted.The perceval plus valve was removed and a crown valve was implanted without any incident.Patient¿s recovery went well.The manufacturer was informed that no further information will be received regarding this event at this time.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PERCEVAL PLUS SUTURELESS AORTIC HEART VALVE
Type of Device
TISSUE HEART VALVES
Manufacturer (Section D)
CORCYM CANADA CORP.
5005 north fraser way
burnaby, bc V5J 5 M1
CA  V5J 5M1
Manufacturer (Section G)
CORCYM CANADA CORP.
5005 north fraser way
burnaby, bc V5J 5 M1
CA   V5J 5M1
Manufacturer Contact
francesca crovato
5005 north fraser way
burnaby, bc V5J 5-M1
CA   V5J 5M1
MDR Report Key14359125
MDR Text Key291405556
Report Number3004478276-2022-00147
Device Sequence Number1
Product Code LWR
UDI-Device Identifier00896208000825
UDI-Public(01)00896208000825(240)PVF-XL(17)221217
Combination Product (y/n)N
Reporter Country CodeCA
PMA/PMN Number
P150011/S013
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 05/11/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/11/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date12/17/2022
Device Model NumberPVF-XL
Device Catalogue NumberPVF-XL
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received04/13/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/17/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age45 YR
Patient SexMale
-
-